ATE524180T1 - Mittel zur prophylaxe oder behandlung von alkoholabhängigkeit oder drogenabhängigkeit - Google Patents
Mittel zur prophylaxe oder behandlung von alkoholabhängigkeit oder drogenabhängigkeitInfo
- Publication number
- ATE524180T1 ATE524180T1 AT07830236T AT07830236T ATE524180T1 AT E524180 T1 ATE524180 T1 AT E524180T1 AT 07830236 T AT07830236 T AT 07830236T AT 07830236 T AT07830236 T AT 07830236T AT E524180 T1 ATE524180 T1 AT E524180T1
- Authority
- AT
- Austria
- Prior art keywords
- prophylaxis
- treatment
- agents
- drug addiction
- alcohol dependence
- Prior art date
Links
- 208000011117 substance-related disease Diseases 0.000 title abstract 3
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 208000007848 Alcoholism Diseases 0.000 title 1
- 201000007930 alcohol dependence Diseases 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 206010013663 drug dependence Diseases 0.000 title 1
- PJANMOWVUZBDQF-XMMPIXPASA-N 2-[3-[1-[(1r)-1,2-dihydroacenaphthylen-1-yl]piperidin-4-yl]-2-oxobenzimidazol-1-yl]-n-methylacetamide Chemical compound C1=CC([C@H](N2CCC(CC2)N2C3=CC=CC=C3N(C2=O)CC(=O)NC)C2)=C3C2=CC=CC3=C1 PJANMOWVUZBDQF-XMMPIXPASA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000009032 substance abuse Diseases 0.000 abstract 1
- 231100000736 substance abuse Toxicity 0.000 abstract 1
- 201000006152 substance dependence Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Addiction (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06122336 | 2006-10-16 | ||
| PCT/JP2007/070502 WO2008050698A2 (en) | 2006-10-16 | 2007-10-16 | Agent for prophylaxis or treatment of alcohol dependence or drug dependence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE524180T1 true ATE524180T1 (de) | 2011-09-15 |
Family
ID=37806857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07830236T ATE524180T1 (de) | 2006-10-16 | 2007-10-16 | Mittel zur prophylaxe oder behandlung von alkoholabhängigkeit oder drogenabhängigkeit |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8207201B2 (de) |
| EP (1) | EP2089030B1 (de) |
| JP (1) | JP5089687B2 (de) |
| KR (1) | KR101187509B1 (de) |
| CN (1) | CN101600433B (de) |
| AT (1) | ATE524180T1 (de) |
| AU (1) | AU2007310209B2 (de) |
| BR (1) | BRPI0717161A2 (de) |
| CA (1) | CA2666630C (de) |
| DK (1) | DK2089030T3 (de) |
| ES (1) | ES2370276T3 (de) |
| MX (1) | MX2009004012A (de) |
| PL (1) | PL2089030T3 (de) |
| PT (1) | PT2089030E (de) |
| RU (1) | RU2419433C2 (de) |
| WO (1) | WO2008050698A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201016675A (en) * | 2008-09-16 | 2010-05-01 | Mitsubishi Tanabe Pharma Corp | Crystalline benzoimidazole compound and salt thereof |
| TWI582096B (zh) * | 2011-12-06 | 2017-05-11 | 美國禮來大藥廠 | 用於酒精依賴及濫用處理之４',５'－二氫螺［哌啶－４,７'－噻吩并[２，３－c]哌喃］化合物 |
| CN117642389A (zh) * | 2021-07-14 | 2024-03-01 | 宜昌人福药业有限责任公司 | 一种哌啶衍生物及其药物组合物、制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1049689T3 (da) * | 1998-01-19 | 2002-07-22 | Pfizer | 4-(2-keto-1-benzimidazolinyl)piperidinderivater som ORL1-receptoragonister |
| US7566728B2 (en) * | 2002-03-29 | 2009-07-28 | Mitsubishi Tanabe Pharma Corporation | Remedy for sleep disturbance |
| AR045939A1 (es) * | 2003-09-25 | 2005-11-16 | Solvay Pharm Bv | Derivados de bencimidazolona y quinazolinona como agonistas de los receptores orl 1 humanos |
| WO2006025267A1 (ja) * | 2004-08-31 | 2006-03-09 | Mitsubishi Pharma Corporation | Per2タンパク質レベルの低下を作用機序とする睡眠障害治療薬 |
| TW201016675A (en) * | 2008-09-16 | 2010-05-01 | Mitsubishi Tanabe Pharma Corp | Crystalline benzoimidazole compound and salt thereof |
-
2007
- 2007-10-16 WO PCT/JP2007/070502 patent/WO2008050698A2/en active Application Filing
- 2007-10-16 MX MX2009004012A patent/MX2009004012A/es active IP Right Grant
- 2007-10-16 RU RU2009118439/15A patent/RU2419433C2/ru not_active IP Right Cessation
- 2007-10-16 AT AT07830236T patent/ATE524180T1/de active
- 2007-10-16 BR BRPI0717161-7A patent/BRPI0717161A2/pt not_active IP Right Cessation
- 2007-10-16 JP JP2009515664A patent/JP5089687B2/ja not_active Expired - Fee Related
- 2007-10-16 CA CA2666630A patent/CA2666630C/en not_active Expired - Fee Related
- 2007-10-16 ES ES07830236T patent/ES2370276T3/es active Active
- 2007-10-16 EP EP07830236A patent/EP2089030B1/de not_active Not-in-force
- 2007-10-16 AU AU2007310209A patent/AU2007310209B2/en not_active Ceased
- 2007-10-16 DK DK07830236.1T patent/DK2089030T3/da active
- 2007-10-16 CN CN2007800386397A patent/CN101600433B/zh not_active Expired - Fee Related
- 2007-10-16 PL PL07830236T patent/PL2089030T3/pl unknown
- 2007-10-16 US US12/311,861 patent/US8207201B2/en not_active Expired - Fee Related
- 2007-10-16 PT PT07830236T patent/PT2089030E/pt unknown
- 2007-10-16 KR KR1020097010031A patent/KR101187509B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2009118439A (ru) | 2010-11-27 |
| CN101600433A (zh) | 2009-12-09 |
| KR101187509B1 (ko) | 2012-10-02 |
| JP2010505746A (ja) | 2010-02-25 |
| RU2419433C2 (ru) | 2011-05-27 |
| AU2007310209B2 (en) | 2011-11-17 |
| ES2370276T3 (es) | 2011-12-14 |
| AU2007310209A1 (en) | 2008-05-02 |
| MX2009004012A (es) | 2009-04-27 |
| EP2089030A2 (de) | 2009-08-19 |
| KR20090069336A (ko) | 2009-06-30 |
| BRPI0717161A2 (pt) | 2013-10-15 |
| EP2089030B1 (de) | 2011-09-14 |
| US8207201B2 (en) | 2012-06-26 |
| CA2666630A1 (en) | 2008-05-02 |
| WO2008050698A3 (en) | 2008-10-02 |
| JP5089687B2 (ja) | 2012-12-05 |
| PT2089030E (pt) | 2011-09-27 |
| US20100069382A1 (en) | 2010-03-18 |
| WO2008050698A2 (en) | 2008-05-02 |
| CA2666630C (en) | 2012-01-24 |
| CN101600433B (zh) | 2012-09-26 |
| PL2089030T3 (pl) | 2012-02-29 |
| DK2089030T3 (da) | 2011-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200615266A (en) | Organic compounds | |
| NO20070557L (no) | Ftalazinderivater som PARP-inhibitorer | |
| NO20090628L (no) | Pyridizinon derivativater | |
| EA200970447A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
| MY148375A (en) | Delta and epsilon crystal forms of imatinib mesylate | |
| EA200900613A1 (ru) | Спирокетоновые ингибиторы ацетил-коа-карбоксилаз | |
| DE602006017694D1 (de) | C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden | |
| EA200970595A1 (ru) | Производные замещенных индазолов, активные в качестве ингибиторов киназ | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| DE602006020871D1 (de) | Lineare harnstoffmimetika-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden | |
| MX2009011276A (es) | Inhibidor de dpp-iv que incluye el grupo beta-amino, metodo para la preparacion del mismo y composicion farmaceutica que contiene el mismo para prevenir y tratar una diabetes o una obesidad. | |
| DK2054418T3 (da) | Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer | |
| MX2007004248A (es) | Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa. | |
| EA201170680A1 (ru) | Ингибиторы акт и p70 s6-киназы | |
| EA200970532A1 (ru) | Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола | |
| EA201270590A1 (ru) | Ингибиторы акт | |
| IL205697A0 (en) | 4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazole-2-yl)benzenesulfon-amide derivatives, compositions comprising the same and uses thereof | |
| DE602005010744D1 (de) | Piperazinylpyridinderivate als mittel gegen adipositas | |
| ZA200704913B (en) | 3-[2-(3-acylamino-2-oxo-2H-pyridin-1-YL)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors | |
| NO20071314L (no) | Peptidiske vasopressinreseptoragonister | |
| PH12019500394A1 (en) | Bicyclic nitrogenated heterocyclic compound | |
| EA201001747A1 (ru) | Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств | |
| DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
| ATE384529T1 (de) | Synergistische kombination enthaltend roflumilast und einen anticholinergischen wirkstoff ausgewählt aus tiotropiumsalzen für die behandlung von atemwegserkrankungen | |
| EA201101119A1 (ru) | Дозируемая форма, содержащая пантопразол в качестве активного ингредиента |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2089030 Country of ref document: EP |